Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus

Introduction: Dipeptidyl peptidase-4 (DPP-4) has been hypothesized to improve responsiveness to erythropoiesis-stimulating agent (ESA). We aimed to describe the trend in DPP-4 inhibitor prescription patterns and assess the association between DPP-4 inhibitor prescription and ESA hyporesponsiveness (...

詳細記述

書誌詳細

出版年:	Kidney & Blood Pressure Research
主要な著者:	Takeshi Hasegawa, Junhui Zhao, Brian Bieber, Jarcy Zee, Ronald L. Pisoni, Bruce M. Robinson, Norio Hanafusa, Masaomi Nangaku
フォーマット:	論文
言語:	英語
出版事項:	Karger Publishers 2021-04-01
主題:	dipeptidyl peptidase-4 inhibitor erythropoiesis-stimulating agent hemodialysis diabetes mellitus
オンライン･アクセス:	https://www.karger.com/Article/FullText/515704